Drug Sales Bring Huge Profits,
and Scrutiny, to Cancer Doctors
by Reed Abelson,
New York Times, 26th Jan, 2003

Among cancer doctors, it is called the chemotherapy concession. At a time when overall spending on prescription drugs is soaring, cancer specialists are pocketing hundreds of millions of dollars each year by selling drugs to patients - a practice that almost no other doctors follow. The cancer specialists can make huge sums - often the majority of their practice revenue - from the difference between what they pay for the drugs and what they charge insurers and government programs. But some private health insurers are now studying ways to reduce these profits, and the issue is getting close attention in Congress.
Story at http://www.nytimes.com/2003/01/26/business/26CANC.html?tntemail1

CTM COMMENT: Within this story lie all the gross morality and ethics issues concerning the vested interests inherent in modern conventional cancer care. The fact that a) cancer doctors can buy the chemotherapy drugs themselves, "often at prices discounted by drug manufacturers trying to sell more of their products, and then administer them intravenously to patients in their offices," and b) that it "creates a potential conflict of interest for these doctors," should warrant a far more pointed critique from The New York Times than the above lame observations. For the full picture on 21st century conventional cancer treatments and non-conventional protocols for recovery, please refer to the Credence titles Cancer: Why Were Still Dying to Know The Truth and Great News on Cancer in the 21st Century.
www.credence.org